LSN announces that Sougato Das has joined the company as President and Chief Operating Officer. Sougato will oversee the growth and management of the RESI Conferences and the Investor and Licensing Partner Database business units. Under his leadership, LSN will expand its focus from early-stage life science funding – covering seed, Series A, and Series B – to a comprehensive approach spanning all stages from seed to exit.
Sougato brings extensive experience in partnering conferences, data platforms, and the biopharma industry. Previously, he served as General Manager of the events and data business at Inpart, following successful exits from two biopharma data-focused startups. He has held senior roles in partnering and marketing at BIO and Clarivate and provided consulting expertise to organizations such as J&J, Merck, GSK, Sanofi, Siemens Medical, and IQVIA.
With Sougato leading these core business areas, Dennis Ford, Founder and CEO of LSN, will focus on launching LSN Labs, a global accelerator platform designed to help life science companies succeed in their Global Partnering Campaigns. LSN Labs aims to address the staggering 95% failure rate of life science startups within their first five years. Ford envisions LSN Labs as a transformative solution, offering enhanced entrepreneurial education, superior partner matching, and an AI-driven agent to help CEOs map and navigate the global partnering landscape from seed to exit.
Next Phase Newsletter 
Leave a comment